DNA technology

#DNA technology #Gene synthesis #Gene therapy #Protein design

Cell-free DNA programme could ‘empower’ therapeutics to market

A newly accessible cell-free DNA programme could “empower” therapeutics to market, the CEO of Ribbon Bio has said. Jodi Barrientos, CEO of the synthetic biology company, was speaking at the ‘Engineering Biology: DNA and Beyond’ conference in Vienna, Austria, which took place on the 5 and 6 March. At the… Read More

#News

Covid-19 vaccine
#Covid-19 #DNA technology #Drug discovery #Immunology / Virology & Vaccines #Infectious diseases

The potential of DNA platforms for infectious disease vaccines 

Stacy R. Lindborg, President and Chief Executive Officer of IMUNON, discusses why research is needed to inform better strategies for infectious diseases such as Covid-19 and a new, multivalent non-viral DNA approach to vaccine development that has the potential to address continued unmet needs in the field. … Read More

#Exclusive Content

Laboratory technology
#AI / data analytics / healthtech / informatics #Artificial intelligence (AI) #Charles River #Collaboration #DNA technology #High throughput screening #Medicinal chemistry #Partnership #Pioneering Medicines

Partners enter multi-programme drug discovery agreement

Charles River Laboratories and Pioneering Medicines have entered a multi-programme agreement that gives Pioneering Medicines access to artificial intelligence (AI) model Logica.  Through the agreement, Pioneering Medicines will apply Logica across a portfolio of targets with the aim of creating optimised small molecules… Read More

#News

#DNA technology #Drug discovery #Podcast #Recombinant DNA #Target identification #Target validation

Recombinant DNA technology and its impact on drug discovery: Podcast

The latest DDW Sitting Down With sponsored podcast features Yuning Chen, Senior R&D Manager at Sino Biological. Recombinant production is a field in which Sino Biological has extensive expertise – the company boasts several platforms to use recombinant DNA technology for the manufacturing of a variety of proteins and… Read More

#News

#DNA technology #Drug discovery #Podcast #Recombinant DNA #Sitting Down With #Target identification #Target validation

Recombinant DNA technology and its impact on modern drug discovery

The latest DDW Sitting Down With sponsored podcast features Yuning Chen, Senior R&D Manager at Sino Biological. Recombinant production is a field in which Sino Biological has extensive expertise – the company boasts several platforms to use recombinant DNA technology for the manufacturing of a variety of proteins and… Read More

#Podcasts